Detalles de la búsqueda
1.
Characterization of a Novel Capsid Assembly Modulator for the Treatment of Chronic Hepatitis B Virus Infection.
Antimicrob Agents Chemother
; 67(1): e0134822, 2023 01 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36519892
2.
Establishment and Characterization of an HBV Viral Spread and Infectious System following Long-Term Passage of an HBV Clinical Isolate in the Primary Human Hepatocyte and Fibroblast Coculture System.
J Virol
; 96(18): e0084922, 2022 09 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36037476
3.
Targeting the hepatitis B cccDNA with a sequence-specific ARCUS nuclease to eliminate hepatitis B virus in vivo.
Mol Ther
; 30(9): 2909-2922, 2022 09 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35581938
4.
Transcriptomic Analysis of Livers of Inactive Carriers of Hepatitis B Virus With Distinct Expression of Hepatitis B Surface Antigen.
J Infect Dis
; 225(6): 1081-1090, 2022 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34279652
5.
Multi-parametric analysis of human livers reveals variation in intrahepatic inflammation across phases of chronic hepatitis B infection.
J Hepatol
; 77(2): 332-343, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35218813
6.
Characterization of Hepatitis B Precore/Core-Related Antigens.
J Virol
; 95(3)2021 01 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33148795
7.
Targeted Long-Read Sequencing Reveals Comprehensive Architecture, Burden, and Transcriptional Signatures from Hepatitis B Virus-Associated Integrations and Translocations in Hepatocellular Carcinoma Cell Lines.
J Virol
; 95(19): e0029921, 2021 09 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34287049
8.
Analysis of Hepatitis B Virus Haplotype Diversity Detects Striking Sequence Conservation Across Genotypes and Chronic Disease Phase.
Hepatology
; 73(5): 1652-1670, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32780526
9.
Characterization of Hepatitis B virus polymerase mutations A194T and CYEI and tenofovir disoproxil fumarate or tenofovir alafenamide resistance.
J Viral Hepat
; 28(1): 30-39, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32894807
10.
Developing a sensitive HBV genotyping assay for HBV DNA suppressed patients using both DNA and RNA sequencing.
J Med Virol
; 92(12): 3420-3425, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32609910
11.
Reply to: "Hepatocyte expression of hepatitis B surface and core antigens across phases of chronic hepatitis B infection".
J Hepatol
; 77(5): 1457, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35977609
12.
Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients.
Antimicrob Agents Chemother
; 61(2)2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27872061
13.
Mechanism for neutralizing activity by the anti-CMV gH/gL monoclonal antibody MSL-109.
Proc Natl Acad Sci U S A
; 111(22): 8209-14, 2014 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-24843144
14.
A neutralizing anti-gH/gL monoclonal antibody is protective in the guinea pig model of congenital CMV infection.
PLoS Pathog
; 10(4): e1004060, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24722349
15.
Phase 1 Randomized, Double-Blind, Placebo-Controlled Study of RG7667, an Anticytomegalovirus Combination Monoclonal Antibody Therapy, in Healthy Adults.
Antimicrob Agents Chemother
; 59(8): 4919-29, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26055360
16.
Antibodies against the gH/gL/UL128/UL130/UL131 complex comprise the majority of the anti-cytomegalovirus (anti-CMV) neutralizing antibody response in CMV hyperimmune globulin.
J Virol
; 86(13): 7444-7, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22532696
17.
Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg-positive chronic hepatitis B.
Aliment Pharmacol Ther
; 57(5): 509-523, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36427857
18.
Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells.
JHEP Rep
; 5(4): 100664, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36908748
19.
Ongoing viral replication and production of infectious virus in patients with chronic hepatitis B virus suppressed below the limit of quantitation on long-term nucleos(t)ide therapy.
PLoS One
; 17(4): e0262516, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35363817
20.
Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infection.
JHEP Rep
; 4(1): 100388, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34950863